Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

1.1 List of Figures
1.2 List of Tables

2.1 Executive Summary
2.2 Key Highlights: Facts about the Egypt Healthcare Market
2.3 Key Highlights: Healthcare Startups in Egypt
2.4 Key Events: Egypt Healthcare Industry, 2016-22
2.5 Key Events: Egypt Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-22
2.7 Key Events: Top Completed Deals by Value, 2020-22
2.8 Country Profile, Egypt, 2022

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Egypt
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Egypt
3.7 COVID-19 Epidemiology, Egypt
3.8 COVID-19 Impact and Developments, Egypt
3.9 COVID-19 Impact and Developments in the Healthcare Market, Egypt
3.10 COVID-19 Clinical Trials Landscape, Egypt
3.11 Pharmaceutical Market - Major Players

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5.1 Drivers
5.2 Barriers

6.1 Deal Analysis: Pharmaceutical Market, Egypt, 2020-22
6.2 Deal Analysis: Medical Device Market, Egypt, 2020-22

7.1 HealthTech Landscape, Egypt
7.2 HealthTech Deals Landscape, Egypt
7.3 Key HealthTech Deals, Egypt
7.4 Adoption of Technology in Healthcare, Egypt
7.5 Digital Statistics, Egypt
7.6 Digital Healthcare Regulations, Egypt
7.7 HealthTech Landscape: Benefits and Risks, Egypt

8.1 Overview of Healthcare System, Egypt
8.2 Reimbursement Process, Egypt
8.3 Overview of Public and Private Insurance Providers, Egypt
8.4 Healthcare Spending and Health Price Trends, Egypt
8.5 Pricing Policies, Egypt
8.6 Market Access: Key Events Timeline, Egypt, 2010-21
8.7 Regulatory Landscape, Egypt
8.7.1 Overview of Regulatory Agencies, Egypt
8.7.2 Marketing Authorization for Pharmaceutical Products, Egypt
8.7.3 Marketing Authorization for Medical Devices, Egypt
8.7.4 Intellectual Property Rights, Patent, Egypt
8.7.5 Intellectual Property Rights, Trademark, Egypt
8.7.6 Clinical Trial Regulation Process, Egypt
8.7.7 Pharmaceutical Clinical Trials Landscape, Egypt
8.7.8 Medical Device Clinical Trials Landscape, Egypt
8.7.9 Pharmaceutical Product Export Regulations, Egypt
8.7.10 Pharmaceutical Product Import Regulations, Egypt
8.7.11 Pharmaceutical Advertising Regulations, Egypt
8.7.12 Labeling and Packaging Regulations, Egypt

9.1 Egypt Healthcare Policy Highlights
9.2 Healthcare Facilities, Egypt
9.3 Life Expectancy and Immunization Rate, Egypt
9.4 Environmental Health, Egypt
9.5 Healthcare Personnel, Egypt
9.6 Disease Burden, Egypt
9.7 Healthcare Expenditure, Egypt

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

Table 1: Pharmaceutical price mark-ups, Egypt, 2018
Table 2: Major therapeutic areas by costs of treatment, Egypt, 2020
Table 3: COVID-19 indicators (number), Egypt and Global, 2022
Table 4: Top COVID-19 markets by product categories (number of available marketed products), Egypt, 2020-22
Table 5: Available COVID-19 vaccines, Egypt, 2022
Table 6: Medical devices market, major segments ($M), Egypt, 2021
Table 7: Classification of medical devices, Egypt, 2022
Table 8: Patent fees, Egypt, 2022
Table 9: Trade fairs, Egypt, 2022

Figure 1: Pharmaceutical market, revenue (EGPB and $B), Egypt, 2014-21
Figure 2: Medical devices market, revenue ($B), Egypt, 2016-22
Figure 3: Healthcare startups in Egypt, 2022
Figure 4: Country profile, Egypt, 2022
Figure 5: Pharmaceutical market, revenue (EGPB and $B), Egypt, 2014-21
Figure 6: Pharmaceutical market, revenue forecast (EGPB and $B), Egypt, 2022-27
Figure 7: Pharmaceutical exports ($M), Egypt, 2014-21
Figure 8: Top export partners, Egypt, 2021
Figure 9: Pharmaceutical imports ($B), Egypt, 2014-21
Figure 10: Top import partners, Egypt, 2021
Figure 11: Pharmaceutical supply channels, Egypt, 2022
Figure 12: Top medical tourism clinics and hospitals, Egypt, 2022
Figure 13: Common treatments offered to medical tourists, Egypt, 2022
Figure 14: OTC medicines market, revenue ($M), Egypt, 2016-21
Figure 15: OTC market by sub-categories of drugs, revenue ($M), Egypt, 2021
Figure 16: Major therapeutic areas by costs of treatment, Egypt, 2020
Figure 17: COVID-19 (number of cases), Egypt, 2020-22
Figure 18: COVID-19 (number of deaths), Egypt, 2020-22
Figure 19: Stringency index, COVID-19, Egypt, 2020-22
Figure 20: Containment and health index, COVID-19, Egypt, 2020-22
Figure 21: Top COVID-19 markets by product categories (number of available marketed products), Egypt, 2020-22
Figure 22: COVID-19 vaccine doses administration, number of vaccine doses administered, Egypt, 2021-22
Figure 23: COVID-19 vaccine booster doses administration, number of booster doses administered per 100 population, Egypt, 2022
Figure 24: COVID-19 clinical trial sponsors by trial count, Egypt, 2020-22
Figure 25: COVID-19 clinical trials count by phase, Egypt, 2020-22
Figure 26: COVID-19 clinical trials count by trial status, Egypt, 2020-22
Figure 27: Medical devices market, revenue ($B), Egypt 2016-21
Figure 28: Medical devices market, revenue forecast ($B), Egypt 2022-27
Figure 29: Medical devices market, major segments (%), Egypt, 2021
Figure 30: Hospital supplies market, revenue ($M), Egypt, 2017-27
Figure 31: Cardiovascular devices market, revenue ($M), Egypt, 2017-27
Figure 32: Orthopedic devices market, revenue ($M), Egypt, 2017-27
Figure 33: General surgery devices market, revenue ($M), Egypt, 2017-27
Figure 34: Wound care management devices market, revenue ($M), Egypt, 2017-27
Figure 35: Diagnostics market, revenue ($M), Egypt, 2016-21
Figure 36: Diagnostics market, revenue forecast ($M), Egypt, 2022-27
Figure 37: Medical devices market, revenue ($B) of major companies, Egypt, 2021
Figure 38: Deal value and deal count, pharmaceutical market, Egypt, 2020-22
Figure 39: Deal value and deal count, quarterly, pharmaceutical market, Egypt, 2020-22
Figure 40: Deal value and deal count subtypes, pharmaceutical market, Egypt, 2020-22
Figure 41: Deal value and deal count, medical devices market, Egypt, 2020-22
Figure 42: Deal value and deal count, quarterly, medical devices market, Egypt, 2020-22
Figure 43: Deal value and deal count subtypes, medical devices market, Egypt, 2020-22
Figure 44: Top equipment sectors by deal value ($M), medical devices market, Egypt, 2020-22
Figure 45: Top equipment sectors by deal count, medical devices market, Egypt, 2020-22
Figure 46: M&A deals, quarterly (by value and by number), medical devices market, Egypt, 2020-22
Figure 47: VC deals quarterly, (by value and by number), medical devices market, Egypt, 2020-22
Figure 48: Deal value ($M) and deal count (number of deals), HealthTech, Egypt, 2020-22
Figure 49: Deal value ($M) and deal count (number of deals) by deal sub-category, HealthTech, Egypt, 2020-22
Figure 50: Overview of healthcare system, Egypt, 2022
Figure 51: Medicine reimbursement process, Egypt, 2022
Figure 52: New governance structure of the UHI System as per the UHI Law, Egypt, 2019
Figure 53: OOP expenditure (% of total expenditure on health), Egypt, 2012-21
Figure 54: Annual rate of change in healthcare Consumer Price Index (CPI) (base year= 2019), Egypt, 2013-20
Figure 55: Egyptian Drug Authority, organization chart, Egypt, 2022
Figure 56: EDA drug approval process part 1, Egypt, 2022
Figure 57: EDA drug approval process part 2, Egypt, 2022
Figure 58: Organization structure for clinical trial regulation, Egypt, 2022
Figure 59: Pharmaceutical clinical trials count by trial status, Egypt, 2021-22
Figure 60: Pharmaceutical clinical trials count by phase, Egypt, 2021-22
Figure 61: Top five pharmaceutical clinical trials sponsors by count, Egypt, 2021-22
Figure 62: Pharmaceutical clinical trials count by therapy area, Egypt, 2021-22
Figure 63: Medical device clinical trials count by trial status, Egypt, 2021-22
Figure 64: Medical device clinical trials count by market categories, Egypt, 2021-22
Figure 65: Top five medical device clinical trials sponsors by count, Egypt, 2021-22
Figure 66: Medical device clinical trials count by therapy area, Egypt, 2021-22
Figure 67: Labeling on pharmaceutical products, Egypt, 2022
Figure 68: Labeling elements of medical devices, Egypt, 2022
Figure 69: Number of hospital beds (per 1,000 population), Egypt, 2015-22
Figure 70: Number of hospitals, Egypt, 2015-22
Figure 71: Number of beds by type in authorities supervised by the Ministry of Health and Population, Egypt, 2019
Figure 72: Number of CT scanners (absolute units), Egypt, 2015-22
Figure 73: Number of MRI units (absolute units), Egypt, 2015-22
Figure 74: Immunization rate (%), Egypt, 2015-22
Figure 75: Life expectancy of males and females at birth (years), Egypt, 2015-22
Figure 76: CO2 emissions (million tons), Egypt, 2015-22
Figure 77: PM2.5 (µg per m3), Egypt, 2015-22
Figure 78: Doctors (per 1,000 population), Egypt, 2015-22
Figure 79: Dentists (per 1,000 population), Egypt, 2015-22
Figure 80: Pharmacists (per 1,000 population), Egypt, 2015-22
Figure 81: Nurses (per 1,000 population), Egypt, 2015-22
Figure 82: Major causes of mortality (per 100,000 population), Egypt, 2019
Figure 83: Major causes of male mortality (per 100,000 population), Egypt, 2019
Figure 84: Major causes of female mortality (per 100,000 population), Egypt, 2019
Figure 85: DALYs by major disease (per 100,000 population), Egypt, 2019
Figure 86: Healthcare expenditure as a percentage of GDP (%), Egypt, 2015-22
Figure 87: Health expenditure share (% of total health spending), Egypt, 2015-22